LAVA Therapeutics N.V. (LVTX) Misses Q2 EPS by 2c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q2 EPS of ($0.32), $0.02 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• St. James's Place plc (STJ:LN) (STJPF) PT Raised to GBP20.50 at Deutsche Bank
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat